Eagle Pharmaceuticals Inc... (EGRX)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
0.62
-0.08 (-11.43%)
At close: Jan 15, 2025, 10:04 AM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
PE Ratio | n/a | 10.61 | -77.03 | 52.37 | 57.74 | 18.65 | 15.53 | 15.13 | 525.96 | -7.01 | -22.42 | -7 |
PS Ratio | n/a | 1.19 | 3.87 | 3.34 | 4.22 | 2.79 | 3.41 | 6.50 | 20.42 | 6.59 | 9.91 | 53.41 |
PB Ratio | n/a | 1.62 | 3.77 | 3.38 | 4.61 | 3.70 | 4.50 | 8.15 | 14.97 | 3.81 | 66.02 | -11.21 |
P/FCF Ratio | n/a | 7.48 | 23.82 | 12.88 | 14.97 | 11.39 | 15.01 | 37.90 | -116.58 | -9.07 | -22.9 | -8.7 |
P/OCF Ratio | n/a | 7.46 | 23.55 | 12.68 | 14.76 | 11.36 | 13.69 | 23.16 | -139.15 | -9.1 | -23.06 | -8.72 |
OCF/S Ratio | n/a | 0.16 | 0.16 | 0.26 | 0.29 | 0.25 | 0.25 | 0.28 | -0.15 | -0.72 | -0.43 | -6.12 |
Debt / Equity Ratio | n/a | 0.29 | 0.15 | 0.20 | 0.22 | 0.28 | 0.27 | n/a | n/a | n/a | n/a | -0.71 |
Quick Ratio | n/a | 1.27 | 2.03 | 4.15 | 4.45 | 3.92 | 3.88 | 2.65 | 3.13 | 2.55 | 1.09 | 0.42 |
Current Ratio | n/a | 1.70 | 2.32 | 4.36 | 4.62 | 4.13 | 3.99 | 2.71 | 3.57 | 2.61 | 1.22 | 0.42 |
Asset Turnover | n/a | 0.78 | 0.68 | 0.74 | 0.77 | 0.89 | 0.88 | 0.89 | 0.53 | 0.36 | 0.76 | 0.27 |
Interest Coverage | n/a | 20.01 | -1.78 | 9.80 | 8.12 | 13.38 | 65.13 | 6.67K | 232.73 | -2.34K | -6.04 | -64.18 |
Return on Equity (ROE) | n/a | 0.15 | -0.05 | 0.06 | 0.08 | 0.20 | 0.29 | 0.54 | 0.03 | -0.54 | -2.94 | 1.60 |
Return on Assets (ROA) | n/a | 0.09 | -0.03 | 0.05 | 0.06 | 0.13 | 0.19 | 0.38 | 0.02 | -0.34 | -0.33 | -2.05 |
Return on Capital (ROIC) | n/a | 0.27 | -0.02 | 0.12 | 0.10 | 0.18 | 0.33 | 0.31 | 0.03 | -0.57 | -2.25 | 1.73 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | 70.01% | 75.41% | 75.79% | 68.91% | 70.97% | 75.84% | 70.81% | 76.37% | 38.67% | 46.04% | -0.25% |
Net Profit Margin | n/a | 11.26% | -5.03% | 6.38% | 7.31% | 14.96% | 21.94% | 42.99% | 3.88% | -94.13% | -44.22% | -7.63% |
Pretax Profit Margin | n/a | 19.40% | -2.65% | 12.07% | 11.23% | 15.96% | 30.82% | 28.20% | 3.89% | -100.91% | -50.79% | -7.94% |
Operating Profit Margin | n/a | 25.57% | -1.7% | 13.45% | 11.14% | 17.17% | 31.26% | 28.16% | 3.87% | -98.21% | -61.81% | -7.81% |
FCF Margin | 9.73% | 29.45% | 14.85% | 24.89% | 25.88% | 22.07% | 28.36% | 49.10% | -60.73% | -101.54% | -233.18% | n/a |
EBITDA Margin | 24.48% | 1.61% | 15.98% | 14.38% | 18.96% | 32.88% | 29.04% | 4.07% | -98.21% | -61.48% | -772.55% | n/a |